Abiopharma

Clinical trial NCT05806164 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-07-15 → 2026-08-30

Clinical trial NCT06692881 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-06-01 3. primary completion date: 2026-05-01 → 2026-06-01

Clinical trial NCT05098132: collaborators added: Merck Sharp & Dohme LLC.

Clinical trial NCT04661358 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 560 → 563 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06819813 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07473323: start date: 2026-05-01 → 2026-05-19.

Clinical trial NCT05698199 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-01 → 2026-06-01 3. primary completion date: 2026-03-01 → 2026-02-11 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07600723: start date: 2026-06-24 → 2026-07-15.

Clinical trial NCT07318324 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-05-13

EMPLOYERS Appoints Jeffrey P. Lisenby as Executive Vice President, General Counsel